SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-089876
Filing Date
2016-03-23
Accepted
2016-03-23 17:18:04
Documents
7
Period of Report
2016-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v435084_8k.htm 8-K 20309
2 EXHIBIT 1.1 v435084_ex1-1.htm EX-1.1 203375
3 EXHIBIT 5.1 v435084_ex5-1.htm EX-5.1 16882
4 EXHIBIT 99.1 v435084_ex99-1.htm EX-99.1 14410
5 GRAPHIC tex5-1logo.jpg GRAPHIC 5378
6 GRAPHIC tex5-1logo1.jpg GRAPHIC 3885
7 GRAPHIC tex99-1logo.jpg GRAPHIC 16983
  Complete submission text file 0001144204-16-089876.txt   292657
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36179 | Film No.: 161524648
SIC: 2834 Pharmaceutical Preparations